An open-label, noncomparative study to evaluate the efficacy, safety, and tolerability of azithromycin in the treatment of patients with acute sinusitis
- 1 July 1995
- journal article
- clinical trial
- Published by Elsevier in Clinical Therapeutics
- Vol. 17 (4) , 701-707
- https://doi.org/10.1016/0149-2918(95)80046-8
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- In-vitro concentration of azithromycin in human phagocytic cellsJournal of Antimicrobial Chemotherapy, 1993
- An open study to compare the pharmacokinetics, safety and tolerability of a multiple-dose regimen of azithromycin in young and elderly volunteersEuropean Journal of Clinical Microbiology & Infectious Diseases, 1991
- Azithromycin concentrations in sinus fluid and mucosa after oral administrationEuropean Journal of Clinical Microbiology & Infectious Diseases, 1991
- The pharmacokinetics of azithromycin in human serum and tissuesJournal of Antimicrobial Chemotherapy, 1990
- Comparison of the acid stability of azithromycin and erythromycin AJournal of Antimicrobial Chemotherapy, 1990
- Bacteriostatic and bactericidal activity of azithromycin against Haemophilus influenzaeJournal of Antimicrobial Chemotherapy, 1990
- In vitro and in vivo uptake of azithromycin (CP-62,993) by phagocytic cells: possible mechanism of delivery and release at sites of infectionAntimicrobial Agents and Chemotherapy, 1989
- Comparative in vitro activities of new 14-, 15-, and 16-membered macrolidesAntimicrobial Agents and Chemotherapy, 1988
- Synthesis, in vitro and in vivo activity of novel 9-deoxo-9a-aza-9a-homoerythromycin A derivatives; A new class of macrolide antibiotics, the azalides.The Journal of Antibiotics, 1987
- Spectrum and mode of action of azithromycin (CP-62,993), a new 15-membered-ring macrolide with improved potency against gram-negative organismsAntimicrobial Agents and Chemotherapy, 1987